247 related articles for article (PubMed ID: 17229869)
1. High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonists.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Quinn MT
Mol Pharmacol; 2007 Apr; 71(4):1061-74. PubMed ID: 17229869
[TBL] [Abstract][Full Text] [Related]
2. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
Forsman H; Kalderén C; Nordin A; Nordling E; Jensen AJ; Dahlgren C
Biochem Pharmacol; 2011 Feb; 81(3):402-11. PubMed ID: 21095183
[TBL] [Abstract][Full Text] [Related]
3. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
[TBL] [Abstract][Full Text] [Related]
4. The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide.
Fu H; Björkman L; Janmey P; Karlsson A; Karlsson J; Movitz C; Dahlgren C
BMC Cell Biol; 2004 Dec; 5(1):50. PubMed ID: 15625007
[TBL] [Abstract][Full Text] [Related]
5. A novel nonpeptide ligand for formyl peptide receptor-like 1.
Nanamori M; Cheng X; Mei J; Sang H; Xuan Y; Zhou C; Wang MW; Ye RD
Mol Pharmacol; 2004 Nov; 66(5):1213-22. PubMed ID: 15308762
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1.
Wan HX; Zhou C; Zhang Y; Sun M; Wang X; Yu H; Yang X; Ye RD; Shen JK; Wang MW
Biochem Pharmacol; 2007 Jul; 74(2):317-26. PubMed ID: 17517377
[TBL] [Abstract][Full Text] [Related]
7. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C
Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1.
Raoof M; Zhang Q; Itagaki K; Hauser CJ
J Trauma; 2010 Jun; 68(6):1328-32; discussion 1332-4. PubMed ID: 20539176
[TBL] [Abstract][Full Text] [Related]
9. F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling.
Lee HY; Lee SY; Shin EH; Kim SD; Kim JM; Lee MS; Ryu SH; Bae YS
Biochem Biophys Res Commun; 2007 Aug; 359(4):985-90. PubMed ID: 17577578
[TBL] [Abstract][Full Text] [Related]
10. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors.
Su SB; Gao Jl; Gong Wh; Dunlop NM; Murphy PM; Oppenheim JJ; Wang JM
J Immunol; 1999 May; 162(10):5924-30. PubMed ID: 10229829
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1.
Zhou C; Zhang S; Nanamori M; Zhang Y; Liu Q; Li N; Sun M; Tian J; Ye PP; Cheng N; Ye RD; Wang MW
Mol Pharmacol; 2007 Oct; 72(4):976-83. PubMed ID: 17652444
[TBL] [Abstract][Full Text] [Related]
12. Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.
Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
J Med Chem; 2006 Aug; 49(17):5232-44. PubMed ID: 16913712
[TBL] [Abstract][Full Text] [Related]
13. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
[TBL] [Abstract][Full Text] [Related]
14. The anti-infective peptide, innate defense-regulator peptide, stimulates neutrophil chemotaxis via a formyl peptide receptor.
Lee HY; Bae YS
Biochem Biophys Res Commun; 2008 May; 369(2):573-8. PubMed ID: 18294454
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor alpha production.
Schepetkin IA; Kirpotina LN; Tian J; Khlebnikov AI; Ye RD; Quinn MT
Mol Pharmacol; 2008 Aug; 74(2):392-402. PubMed ID: 18458054
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors.
Karlsson J; Fu H; Boulay F; Dahlgren C; Hellstrand K; Movitz C
J Leukoc Biol; 2005 Sep; 78(3):762-71. PubMed ID: 15951351
[TBL] [Abstract][Full Text] [Related]
17. Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists.
Edwards BS; Bologa C; Young SM; Balakin KV; Prossnitz ER; Savchuck NP; Sklar LA; Oprea TI
Mol Pharmacol; 2005 Nov; 68(5):1301-10. PubMed ID: 16118363
[TBL] [Abstract][Full Text] [Related]
18. Changes in the ratio between FPR and FPRL1 triggered superoxide production in human neutrophils-a tool in analysing receptor specific events.
Fu H; Karlsson J; Björkman L; Stenfeldt AL; Karlsson A; Bylund J; Dahlgren C
J Immunol Methods; 2008 Feb; 331(1-2):50-8. PubMed ID: 18166194
[TBL] [Abstract][Full Text] [Related]
19. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.
Rabiet MJ; Huet E; Boulay F
Eur J Immunol; 2005 Aug; 35(8):2486-95. PubMed ID: 16025565
[TBL] [Abstract][Full Text] [Related]
20. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1.
Hu JY; Le Y; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM
J Leukoc Biol; 2001 Jul; 70(1):155-61. PubMed ID: 11435499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
